| Acebutolol, Imp. A (EP): | N-[3-Acetyl-4-[(2RS)-oxiran-2-ylmethoxy]phenyl]butanamide | |
| Acebutolol, Imp. B (EP) as Hydrochloride: | N-[3-Acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]-propoxy]phenyl]acetamide Hydrochloride | |
| Acebutolol, Imp. C (EP) | N-(3-Acetyl-4-hydroxyphenyl)butanamide | |
| Acebutolol,Imp. D (EP) | 1-[5-Amino-2-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]-propoxy]phenyl]ethanone Dihydrochloride | |
| Acebutolol,Imp. E (EP) | N-[4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-phenyl]butanamide Hydrochloride | |
| Aceclofenac | 89796-99-6 | 2-[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxyacetic acid |
| Aceclofenac, Imp. A (EP): | [2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid | |
| Aceclofenac ,Imp. B (EP): | Methyl [2-[(2,6-Dichlorophenyl)amino]phenyl]acetate | |
| Aceclofenac, Imp. C (EP) | Ethyl 2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetate | |
| Aceclofenac, Imp. D(EP) | Methyl [[[2-[(2,6-Dichlorophenyl) amino]phenyl]acetyl]oxy]acetate | |
| Aceclofenac, Imp. I (EP) | 1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one | |
| Acesulfame Potassium, Imp. A (EP) | 5977-14-0 | 3-Oxobutanamide |
| Acetazolamide, Imp. A (EP) | N-(5-Chloro-1,3,4-thiadiazol-2-yl)acetamide | |
| Acetazolamide,Imp. B (EP) | N-(1,3,4-Thiadiazol-2-yl)acetamide | |
| Acetylsalicylic Acid, Imp. B (EP) | 4-Hydroxybenzene-1,3-dicarboxylic Acid | |
| Acetylsalicylic Acid ,Imp. E (EP) | 2-[(2-Hydroxybenzoyl)oxy]benzoic Acid | |
| Aciclovir, Imp. A (EP) | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl Acetate | |
| ALFUZOSIN Impurity A | 98902-29-5 | N-[3-[4-amino-6,7-dimethoxy-quinazolin-2-yl)methylamino]propyl]furan-2-carboxamide |
| Atenolol Impurity A | 17194-82-0 | 2-(4-hydroxyphenyl)acetamide |
| Atenolol Impurity B | 61698-76-8 | 2-(4-((oxiran-2-yl)methoxy)phenyl)acetamide |
| Atenolol Impurity C | 29122-69-8 | 2-(4-(2,3-dihydroxypropoxy)phenyl)acetamide |
| Atenolol Impurity D | 2-(4-(3-chloro-2-hydroxypropoxy)phenyl)acetamide | |
| Atorvastatin Lactone | 125995-03-1 | 5-(4-fluorophenyl)-1-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-2-isopropyl-N,4-diphenyl-1Hpyrrole-3-carboxamide |
| Atorvastatin Methyl ester | 345891-62-5 | (3R,5R)-methyl 7-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1Hpyrrol-1-yl)-3,5-dihydroxyheptanoate |
| Atorvastatin isomer (3S, 5S) | (3S,5S)-7-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1Hpyrrol-1-yl)-3,5-dihydroxyheptanoic acid calcium salt | |
| Desfluoro Atorvastatin | (3R,5R)-7-(3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid calcium salt | |
| Atorvastatin L1 | tert-butyl 2-((4R,6R)-6-(2-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate | |
| Atorvastatin Acetonide | 581772-29-4 | 2-((4R,6R)-6-(2-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1Hpyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
| Atorvastatin t-Butyl ester | 134395-00-9 | (βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1,1-Dimethylethyl Ester; |
| O-Hydroxy Atorvastatin | (3R,5R)-7-(3-(2-hydroxyphenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid | |
| Betahistine Impurity A | 100-69-6 | 2-vinylpyridine |
| Betahistine Impurity B | 103-72-4 | 2-(pyridin-2-yl)ethanol |
| BISACODYL Impurity A | 603-41-8 | 4-((4-hydroxyphenyl)(pyridin-2-yl)methyl)phenol |
| CLOPIDOGREL IMPURITY-A | methyl (2-chlorophenyl)(thieno[3,2-c]pyridin-5(4H)-yl)acetate | |
| CLOPIDOGREL IMPURITY-B | methyl (2-chlorophenyl)(4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl)acetate | |
| CITALOPRAM IMPURITY G | 4-(dimethylamino)-1-((R)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-yl)butan-1-one | |
| CINNARIZINE Impurity B | 750512-44-8 | Z)-1-(Diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine |
| CETIRIZINE Impurity C | 2-(2-(4-((R)-1-(2-chlorophenyl)-1-phenylethyl)piperazin-1-yl)ethoxy)acetic acid | |
| CETIRIZINE Impurity E | 2-(2-(2-(4-((R)-1-(4-chlorophenyl)-1-phenylethyl)piperazin-1-yl)ethoxy)ethoxy)acetic acid | |
| CETIRIZINE N-OXIDE | 2-(2-(4-((R)-1-(2-chlorophenyl)-1-phenylethyl)piperazin-1-yl)ethoxy)acetic acid N-oxide | |
| Disopyramide Impurity A | 5005-46-9 | 4-(diisopropylamino)-2-phenyl-2-(pyridin-2-yl)butanenitrile |
| Disopyramide Impurity C | 38236-46-3 | 4-(isopropylamino)-2-phenyl-2-(pyridin-2-yl)butanamide |
| Domperidone Impurity B | 4-(6-chloro-1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)piperidine-1-carbaldehyde | |
| Doxylamine Impurity A | 2-(1-phenyl-1-(pyridin-4-yl)ethoxy)-N,Ndimethylethanamine | |
| Doxylamine Impurity B | 19490-92-7 | 1-phenyl-1-(pyridin-2-yl)ethanol |
| Doxylamine Impurity C | N,N-dimethyl-2-(phenyl(pyridin-2-yl)methoxy)ethanamine | |
| ETODOLAC Impurity A | 41339-67-7 | 2-(1-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid |
| ETOFENAMATE Impurity C | 101-23-5 | 3-(trifluoromethyl)-N-phenylbenzenamine |
| FENOFIBRATE Impurity B | 42017-89-0 | 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid |
| FENOFIBRATE Impurity F | 154356-96-4 | (4-chlorophenyl)(4-isopropoxyphenyl)methanone |
| FLUCONAZOLE Impurity D | 81886-51-3 | 2-(4-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
| FLUCONAZOLE Impurity H | 150194-52-8 | 1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
| GLICLAZIDE Impurity C | 5577-13-9 | Ethyl [(4-Methylphenyl)sulphonyl]-carbamate |
| Glipizide impurity C | 13554-93-3 | Ethyl [2-[4-[(cyclohexylcarbamoyl)-sulphamoyl]phenyl]ethyl]carbamate |
| Glipizide impurity E | 66375-96-0 | 1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulphonyl] urea |
| GUAIFENESIN Impurity B | 14007-09-01 | 2-(2-methoxyphenoxy)propane-1,3-diol |
| Ketrolac Impurity A | (1-hydroxy-2,3-dihydro-1H-pyrrolizin-5-yl)(phenyl)methanone | |
| Ketrolac Impurity B | 5-(phenylcarbonyl)-2,3-dihydro-1Hpyrrolizin-1-one | |
| Ketrolac Impurity I | 2,3-dihydro-1H-pyrrolizin-5-yl(phenyl)methanone | |
| Lisinopril Impurity A | 2-amino-4-phenylbutanoic acid | |
| Metoprolol impurity-G | 4-(2-hydroxyethyl)phenol | |
| Mebendazole Impurity A | 52329-60-9 | (2-amino-1H -benzimidazol-5-yl)phenylmethanone |
| Mebendazole Impurity B | 21472-33-3 | (2-hydroxy-1H-benzo[d]imidazol-5-yl)(phenyl)methanone |
| Mebendazole Impurity C | 66066-76-0 | (2-amino-1-methyl-1H-benzo[d]imidazol-5-yl)(phenyl)methanone |
| Mebendazole Impurity D | 132119-11-0 | Methyl (5-benzoyl-1-methyl-1H -benzimidazol-2- yl)carbamate |
| METRONIDAZOLE Impurity C | 5006-69-9 | 2-(4-nitro-1H-imidazol-1-yl)ethanol |
| METRONIDAZOLE Impurity F | 16156-94-8 | 2-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy)ethanol |
| METRONIDAZOLE Impurity G | 1010-93-1 | 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetic acid |
| Nimesulide Impurity D | 5422-92-4 | 4-Nitro-2-phenoxyaniline |
| Nizatidine Impurity J | 82586-70-7 | [2-[(dimethylamino)methyl]thiazol-4-yl]methanol |
| Paroxetine Impurity A | 324024-00-2 | (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4- phenylpiperidine hydrochloride |
| Paroxetine Impurity C | 105813-13-6 | (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1- benzyl-4-(4-fluorophenyl)piperidine hydrochloride (Nbenzyl paroxetine) |
| Paroxetin Impurity F | (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1- benzyl-4-phenylpiperidine hydrochloride | |
| Simvastatin Acetate Impurity B | 145576-25-6 | (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(acetyloxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate |
| Simvastatin anhydro Impurity C | 210980-68-0 |
